Related Experiment Video
Updated: Jul 17, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Optimal glucose-insulin control in H2 space
L Kovács1, B Paláncz, Zs Almássy
1Dep. of Control Eng. & Inf. Technol., Budapest Univ. of Technol. & Econ., Hungary.
Summary
This study presents optimal glucose-insulin control for intensive care diabetic patients using advanced control methods. The research demonstrates improved glucose regulation strategies for critical care settings.
Area of Science:
- Biomedical Engineering
- Control Systems Theory
- Diabetology
Background:
- Intensive care diabetic patients require precise glucose-insulin control.
- Traditional control methods may not adequately address dynamic glucose fluctuations.
- Advanced control strategies are needed for optimal glycemic management in critical care.
Purpose of the Study:
- To present optimal glucose-insulin control in the Hardy H2-space for diabetic patients in intensive care.
- To compare the classical LQ optimal control design with the disturbance rejection LQR (LQ rejection) method.
- To simulate and demonstrate the dynamical performance of the closed-loop system under varying conditions.
Main Methods:
- Utilized a modified two-compartment model for glucose-insulin dynamics.
- Applied the classical Linear Quadratic (LQ) optimal control design.
- Implemented the disturbance rejection Linear Quadratic Regulator (LQ rejection) method based on MINIMAX differential game theory.
- Employed Mathematica and Matlab-Simulink for symbolic and numeric computations and simulations.
Main Results:
- Simulations demonstrated the dynamical performance of the non-linear closed-loop system.
- The study showcased the effectiveness of both LQ optimal control and LQ rejection methods.
- Comparative analysis highlighted the benefits of the disturbance rejection approach in managing glucose levels during food intake.
Conclusions:
- Optimal glucose-insulin control strategies, including LQ rejection, are feasible and effective for intensive care diabetic patients.
- The modified two-compartment model provides a robust framework for analyzing glucose-insulin dynamics.
- Advanced control methods offer potential for improved glycemic management in critical care settings.
Related Concept Videos
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...